Tearsheet
Investment Highlights Market Valuation Price Chart About BSX Interactive Breakdown Better Bets vs. BSX Latest Trefis Analyses Trade Ideas Recent Active Movers More From Trefis Peer Financials Peer Growth & Margins Peer Valuation Peer Returns Peer Analyses FDIC Bank Data Financials Segment Financials Price Behavior Short Interest Earnings Returns History SEC Filings Insider Activity Industry Resource Links External Quote Links

Boston Scientific (BSX)

Market Price (10/18/2025): $99.23 | Market Cap: $146.9 Bil
Sector: Health Care | Industry: Health Care Equipment

Boston Scientific (BSX)

Market Price (10/18/2025): $99.23
Market Cap: $146.9 Bil
Sector: Health Care
Industry: Health Care Equipment

Investment Highlights Why It Matters Which of these 2 stories sounds closer for this stock?

1. Generates cash flow

The stock generated 4% or more of the share price (called cash flow yield), and shows moderate 10-15% or more growth.

2. Riding a trend

Think Tesla during the pandemic of 2020 when EVs were riding a cultural high, or Nvidia in the current AI boom, or even Figma. These companies don’t have enough yield, or, enough growth, or both - however - they are riding a trend. They have momentum. These can be more volatile - they don’t have the floor of strong cash flow

0 Attractive cash flow generation
CFO/Rev LTMCash Flow from Operations / Revenue (Sales), Last Twelve Months (LTM) is 23%, FCF/Rev LTMFree Cash Flow / Revenue (Sales), Last Twelve Months (LTM) is 17%, CFO LTM is 4.3 Bil, FCF LTM is 3.2 Bil		  Expensive valuation multiples
P/EBITPrice/EBIT or Price/(Operating Income) ratio is 44x, P/CFOPrice/(Cash Flow from Operations). CFO is cash before capital expenditures. is 34x, P/EPrice/Earnings or Price/(Net Income) is 59x
1 Low stock price volatility
Vol 12M is 23%		  Yield minus risk free rate is negative
ERPEquity Risk Premium (ERP) = Total Yield - Risk Free Rate, Reflects the premium above risk free assets offered by the investment. is -2.8%
0 Attractive cash flow generation
CFO/Rev LTMCash Flow from Operations / Revenue (Sales), Last Twelve Months (LTM) is 23%, FCF/Rev LTMFree Cash Flow / Revenue (Sales), Last Twelve Months (LTM) is 17%, CFO LTM is 4.3 Bil, FCF LTM is 3.2 Bil
1 Low stock price volatility
Vol 12M is 23%
2 Expensive valuation multiples
P/EBITPrice/EBIT or Price/(Operating Income) ratio is 44x, P/CFOPrice/(Cash Flow from Operations). CFO is cash before capital expenditures. is 34x, P/EPrice/Earnings or Price/(Net Income) is 59x
3 Yield minus risk free rate is negative
ERPEquity Risk Premium (ERP) = Total Yield - Risk Free Rate, Reflects the premium above risk free assets offered by the investment. is -2.8%

Market Valuation & Key Metrics

BSXS&P 500
REVENUE GROWTHVERY GOOD
Rev LTM ($ Bil)18.5
Rev Chg Q22.8%6.1%
Rev Chg LTM21.4%5.2%
Rev Chg 3Y Avg14.6%5.4%
PROFITABILITYFAIR
Op Inc LTM ($ Bil)3.4
Op Mgn LTM18.3%18.6%
CFO LTM ($ Bil)4.3
CFO/Rev LTM23.2%20.3%
Net Inc LTM ($ Bil)2.5
Net Inc Mgn13.5%12.7%
VALUATIONVERY HIGH
P/S7.93.2
P/CFO34.315.8
P/FCF45.420.7
P/E58.623.9
STABILITYGOOD
Debt/Equity0.080.22
Cash/Assets0.010.07

BSX Stock

Return vs. Risk

Price Returns Compared

 202020212022202320242025Total [1]
Returns
BSX Return-20%18%9%25%55%9%111%
Peers Return12%13%-21%3%6%-3%6%
S&P 500 Return16%27%-19%24%23%13%103%

Monthly Win Rates [3]
BSX Win Rate42%42%58%58%83%67% 
Peers Win Rate53%50%42%47%53%53% 
S&P 500 Win Rate58%75%42%67%75%67% 

Max Drawdowns [4]
BSX Max Drawdown-43%-2%-17%-3%-0%0% 
Peers Max Drawdown-28%-9%-31%-17%-10%-14% 
S&P 500 Max Drawdown-31%-1%-25%-1%-2%-15% 

[1] Cumulative total returns since the beginning of 2020
[2] Peers: ABT, ISRG, MDT, BDX, BAX. See BSX Returns vs. Peers.
[3] Win Rate = % of calendar months in which monthly returns were positive
[4] Max drawdown represents maximum peak-to-trough decline within a year
[5] 2025 data is for the year up to 10/17/2025 (YTD)

Downturns Compared

Unique KeyEventBSXS&P 500
2022 Inflation Shock2022 Inflation Shock  
2022 Inflation Shock% Loss% Loss-25.2%-25.4%
2022 Inflation Shock% Gain to Breakeven% Gain to Breakeven33.7%34.1%
2022 Inflation ShockTime to BreakevenTime to Breakeven181 days464 days
2020 Covid Pandemic2020 Covid Pandemic  
2020 Covid Pandemic% Loss% Loss-43.5%-33.9%
2020 Covid Pandemic% Gain to Breakeven% Gain to Breakeven77.0%51.3%
2020 Covid PandemicTime to BreakevenTime to Breakeven497 days148 days
2018 Correction2018 Correction  
2018 Correction% Loss% Loss-18.7%-19.8%
2018 Correction% Gain to Breakeven% Gain to Breakeven23.0%24.7%
2018 CorrectionTime to BreakevenTime to Breakeven46 days120 days
2008 Global Financial Crisis2008 Global Financial Crisis  
2008 Global Financial Crisis% Loss% Loss-70.5%-56.8%
2008 Global Financial Crisis% Gain to Breakeven% Gain to Breakeven239.2%131.3%
2008 Global Financial CrisisTime to BreakevenTime to Breakeven2538 days1480 days


How Low Can It Go?

Boston Scientific's stock fell -25.2% during the 2022 Inflation Shock from a high on 4/20/2022. A -25.2% loss requires a 33.7% gain to breakeven.

Preserve Wealth

Limiting losses and compounding gains is essential to preserving wealth over time.

Asset Allocation

Actively managed asset allocation strategies protect wealth. Learn more.

Interactive Breakdown

Boston Scientific Interactive Breakdown Analysis

Better Bets than Boston Scientific (BSX)

 BSXBetter Performance than BSX
MetricValueIndustry (Health Care Equipment)
Rev Chg LTM21.4%PODD (26.0%), GKOS (26.7%), TMDX (64.4%), INSP (22.0%), UFPT (41.0%)
Rev Chg 3Y Avg14.6%ISRG (15.4%), DXCM (17.3%), PODD (26.1%), PEN (16.7%), GMED (44.7%)
Op Mgn LTM18.3%ISRG (28.8%), SYK (19.7%), MDT (19.4%), IDXX (31.1%), EW (27.9%)
CFO/Rev LTM23.2%ISRG (30.9%), RMD (34.0%), HOLX (28.1%), GMED (25.5%), LMAT (25.0%)
FCF/Rev LTM17.5%ISRG (21.8%), IDXX (19.2%), RMD (32.1%), ZBH (17.7%), HOLX (24.1%)
Total Yield1.7%ABT (8.0%), SYK (2.9%), MDT (6.7%), BDX (5.1%), IDXX (1.9%)
 BSXBetter Performance than BSX
MetricValueAll Other Sectors
Rev Chg LTM21.4%NVDA (71.6%), AVGO (28.0%), PLTR (38.8%), AMD (27.2%), MU (48.9%)
Rev Chg 3Y Avg14.6%NVDA (92.0%), AVGO (24.0%), PLTR (25.7%), TM (15.2%), MU (20.3%)
Op Mgn LTM18.3%NVDA (58.1%), MSFT (45.6%), AAPL (31.9%), GOOGL (32.7%), META (42.9%)
CFO/Rev LTM23.2%NVDA (46.6%), MSFT (48.3%), AAPL (26.6%), GOOGL (36.0%), META (56.4%)
FCF/Rev LTM17.5%NVDA (43.6%), MSFT (25.4%), AAPL (23.5%), GOOGL (18.0%), META (30.7%)
Total Yield1.7%NVDA (2.0%), MSFT (3.3%), AAPL (3.0%), GOOGL (4.1%), AMZN (3.1%)
 Best Bets In Health Care Sector
 BSXRPRX HALO CPRX LNTH PBH EW AVTR ILMN HCA UHS
What You Pay           
P/E58.615.414.612.014.114.410.614.711.917.110.4
P/EBIT44.18.111.510.39.69.226.110.010.09.37.2
What You Get           
Rev Chg Q22.8%7.7%40.8%19.4%-4.1%-6.6%11.9%-1.1%-4.8%6.4%9.6%
Rev Chg LTM21.4%3.0%35.0%28.5%5.7%0.6%9.1%-2.3%-3.3%6.4%9.6%
Rev Chg 3Y Avg14.6%0.8%35.5%49.9%34.3%0.8%3.0%-4.3%-3.0%6.6%8.1%
FCF/Rev 3Y Avg13.1%113.4%43.4%38.9%26.1%21.6%11.9%9.7%9.0%8.4%4.9%

[1] Choosing top 10 best bets from each sector quarterly is an alpha producing strategy vs sector benchmark
[2] Historical annualized return of 11%, alpha of 1.9%, and sharpe of 0.52

Latest Trefis Analyses

TitleTopicDate
0DASHBOARDS  
1Boston Scientific Earnings Notes  
2How Low Can Boston Scientific Stock Really Go?Return 
3Day 10 of Loss Streak for Boston Scientific Stock with -10% Return (vs. 8.6% YTD) [9/22/2025]Notification 
4Day 8 of Loss Streak for Boston Scientific Stock with -9.2% Return (vs. 10% YTD) [9/18/2025]Notification 
5Day 7 of Loss Streak for Boston Scientific Stock with -8.9% Return (vs. 10% YTD) [9/17/2025]Notification 
6Day 6 of Loss Streak for Boston Scientific Stock with -8.5% Return (vs. 11% YTD) [9/16/2025]Notification 
7Day 5 of Loss Streak for Boston Scientific Stock with -7.6% Return (vs. 12% YTD) [9/15/2025]Notification 
8Boston Scientific vs Eli Lilly: Which Is A Better Investment?Counter-Intuitive Comparisons 
9How Does Boston Scientific Stock Stack Up Against Its Peers?Peer Comparison 
10Wait For A Dip To Buy Boston Scientific StockBuy or Fear 
11ARTICLES  
12BSX Stock Down -10% after 10-Day Loss Streak September 23rd, 2025
13BSX Stock Down -9.5% after 9-Day Loss Streak September 22nd, 2025
14BSX Stock Down -9.2% after 8-Day Loss Streak September 19th, 2025
15BSX Stock Down -8.9% after 7-Day Loss Streak September 18th, 2025
16BSX Stock Down -8.5% after 6-Day Loss Streak September 17th, 2025
Title
0DASHBOARDS
1BSX Stock Down -10% after 10-Day Loss Streak
2BSX Stock Down -9.5% after 9-Day Loss Streak
3BSX Stock Down -9.2% after 8-Day Loss Streak
4BSX Stock Down -8.9% after 7-Day Loss Streak
5BSX Stock Down -8.5% after 6-Day Loss Streak
6ARTICLES
7Boston Scientific Earnings Notes
8How Low Can Boston Scientific Stock Really Go?
9Day 10 of Loss Streak for Boston Scientific Stock with -10% Return (vs. 8.6% YTD) [9/22/2025]
10Day 8 of Loss Streak for Boston Scientific Stock with -9.2% Return (vs. 10% YTD) [9/18/2025]
11Day 7 of Loss Streak for Boston Scientific Stock with -8.9% Return (vs. 10% YTD) [9/17/2025]
12Day 6 of Loss Streak for Boston Scientific Stock with -8.5% Return (vs. 11% YTD) [9/16/2025]
13Day 5 of Loss Streak for Boston Scientific Stock with -7.6% Return (vs. 12% YTD) [9/15/2025]
14Boston Scientific vs Eli Lilly: Which Is A Better Investment?
15How Does Boston Scientific Stock Stack Up Against Its Peers?
16Wait For A Dip To Buy Boston Scientific Stock

Trade Ideas

Select past ideas related to BSX. For more, see Trefis Trade Ideas.

Unique KeyDateTickerCompanyCategoryTrade Strategy6M Fwd Rtn12M Fwd Rtn12M Max DD
ADMA_9302025_Dip_Buyer_ValueBuy09302025ADMAADMA BiologicsDip BuyDB | P/E OPMDip Buy with Low PE and High Margin
Buying dips for companies with tame PE and meaningfully high operating margin		-0.7%-0.7%-4.6%
REGN_9302025_Dip_Buyer_ValueBuy09302025REGNRegeneron PharmaceuticalsDip BuyDB | P/E OPMDip Buy with Low PE and High Margin
Buying dips for companies with tame PE and meaningfully high operating margin		1.2%1.2%-0.8%
HAE_9262025_Dip_Buyer_High_FCF_Yield_ExInd_DE_RevG09262025HAEHaemoneticsDip BuyDB | FCF Yield | Low D/EDip Buy with High Free Cash Flow Yield
Buying dips for companies with significant free cash flow yield (FCF / Market Cap) and reasonable debt / market cap		3.3%3.3%-0.1%
WAT_9192025_Monopoly_xInd_xCD_Getting_Cheaper09192025WATWatersMonopolyMY | Getting CheaperMonopoly-Like with P/S Decline
Large cap with monopoly-like margins or cash flow generation and getting cheaper based on P/S multiple		11.3%11.3%-4.3%
ISRG_9052025_Monopoly_xInd_xCD_Getting_Cheaper09052025ISRGIntuitive SurgicalMonopolyMY | Getting CheaperMonopoly-Like with P/S Decline
Large cap with monopoly-like margins or cash flow generation and getting cheaper based on P/S multiple		-6.9%-6.9%-8.0%
Unique KeyDateTickerCompanyCategoryTrade Strategy6M Fwd Rtn12M Fwd Rtn12M Max DD
ADMA_9302025_Dip_Buyer_ValueBuy09302025ADMAADMA BiologicsDip BuyDB | P/E OPMDip Buy with Low PE and High Margin
Buying dips for companies with tame PE and meaningfully high operating margin		-0.7%-0.7%-4.6%
REGN_9302025_Dip_Buyer_ValueBuy09302025REGNRegeneron PharmaceuticalsDip BuyDB | P/E OPMDip Buy with Low PE and High Margin
Buying dips for companies with tame PE and meaningfully high operating margin		1.2%1.2%-0.8%
HAE_9262025_Dip_Buyer_High_FCF_Yield_ExInd_DE_RevG09262025HAEHaemoneticsDip BuyDB | FCF Yield | Low D/EDip Buy with High Free Cash Flow Yield
Buying dips for companies with significant free cash flow yield (FCF / Market Cap) and reasonable debt / market cap		3.3%3.3%-0.1%
WAT_9192025_Monopoly_xInd_xCD_Getting_Cheaper09192025WATWatersMonopolyMY | Getting CheaperMonopoly-Like with P/S Decline
Large cap with monopoly-like margins or cash flow generation and getting cheaper based on P/S multiple		11.3%11.3%-4.3%
ISRG_9052025_Monopoly_xInd_xCD_Getting_Cheaper09052025ISRGIntuitive SurgicalMonopolyMY | Getting CheaperMonopoly-Like with P/S Decline
Large cap with monopoly-like margins or cash flow generation and getting cheaper based on P/S multiple		-6.9%-6.9%-8.0%

Recent Active Movers

1 Week Top Gainers

#TickerCompany1W RtnYTD Rtn
1PRAXPraxis Precision Medicines256.7%146.9%
2NVTSNavitas Semiconductor78.1%310.6%
3SSIISS Innovations International40.1%23.4%
4FLNCFluence Energy40.0%15.4%
5BTDRBitdeer Technologies35.1%10.8%
6MVSTMicrovast34.6%181.6%
7POWIPower Integrations31.3%-25.4%
8CCOClear Channel Outdoor30.8%24.1%
9IRONDisc Medicine28.7%41.9%
10BEBloom Energy28.4%402.0%

1 Week Top Losers

#TickerCompany1W RtnYTD Rtn
1SOCSable Offshore-35.8%-48.4%
2SRRKScholar Rock-29.2%-35.4%
3AIVApartment Investment & Management-28.3%-9.0%
4ALABAstera Labs-22.5%20.6%
5BYRNByrna Technologies-19.7%-26.6%
6BWINBaldwin Insurance-19.5%-40.3%
7ONDSOndas-17.5%197.3%
8URGUr-Energy-17.4%40.0%
9IIINInsteel Industries-16.4%14.6%
10LIFLife360-16.0%112.3%

1 Month Top Gainers

#TickerCompany1M RtnYTD Rtn
1WOLFWolfspeed1160.2%365.5%
2PRAXPraxis Precision Medicines320.1%146.9%
3QUREuniQure293.5%228.4%
4FLNCFluence Energy131.4%15.4%
5CLPTClearPoint Neuro123.6%65.0%
6NVTSNavitas Semiconductor117.8%310.6%
7LACLithium Americas110.9%128.6%
8ASTSAST SpaceMobile101.5%295.7%
9BETRBetter Home & Finance97.8%610.2%
10GRALGRAIL97.0%337.0%

1 Month Top Losers

#TickerCompany1M RtnYTD Rtn
1SOCSable Offshore-50.9%-48.4%
2FLYFirefly Aerospace-41.7% 
3PGYPagaya Technologies-39.5%185.3%
4UPWheels Up Experience-37.1%-6.7%
5ALABAstera Labs-36.6%20.6%
6VGVenture Global-35.8% 
7USNAUsana Health Sciences-32.3%-41.8%
8UPSTUpstart-31.7%-24.5%
9DOMODomo-30.8%73.6%
10TROXTronox-30.6%-63.2%

Recent Active Movers

1 Week Top Gainers

#TickerCompany1W RtnYTD Rtn
1PRAXPraxis Precision Medicines256.7%146.9%
2NVTSNavitas Semiconductor78.1%310.6%
3SSIISS Innovations International40.1%23.4%
4FLNCFluence Energy40.0%15.4%
5BTDRBitdeer Technologies35.1%10.8%
6MVSTMicrovast34.6%181.6%
7POWIPower Integrations31.3%-25.4%
8CCOClear Channel Outdoor30.8%24.1%
9IRONDisc Medicine28.7%41.9%
10BEBloom Energy28.4%402.0%

1 Week Top Losers

#TickerCompany1W RtnYTD Rtn
1SOCSable Offshore-35.8%-48.4%
2SRRKScholar Rock-29.2%-35.4%
3AIVApartment Investment & Management-28.3%-9.0%
4ALABAstera Labs-22.5%20.6%
5BYRNByrna Technologies-19.7%-26.6%
6BWINBaldwin Insurance-19.5%-40.3%
7ONDSOndas-17.5%197.3%
8URGUr-Energy-17.4%40.0%
9IIINInsteel Industries-16.4%14.6%
10LIFLife360-16.0%112.3%

More From Trefis

Research & Analysis

Invest in Strategies

Wealth Management

Peer Comparisons for Boston Scientific

Financials

BSXABTISRGMDTBDXBAXMedian
NameBoston S.Abbott L.Intuitiv.MedtronicBecton D.Baxter I. 
Mkt Price99.24128.54446.1395.78189.1023.09113.89
Mkt Cap146.9224.1159.9122.854.311.8134.8
Rev LTM18,49443,1099,14534,20021,38610,88719,940
Op Inc LTM3,3887,5152,6346,6472,9553983,172
FCF LTM3,2346,7751,9945,3032,5502182,892
FCF 3Y Avg2,1145,9721,1974,9642,5046582,309
CFO LTM4,2859,0372,8267,1463,2547653,770
CFO 3Y Avg3,0148,1302,1166,6253,2781,1663,146

Growth & Margins

BSXABTISRGMDTBDXBAXMedian
NameBoston S.Abbott L.Intuitiv.MedtronicBecton D.Baxter I. 
Rev Chg LTM21.4%5.9%20.8%5.0%7.9%3.6%6.9%
Rev Chg 3Y Avg14.6%-1.5%15.4%3.3%4.1%-5.7%3.7%
Rev Chg Q22.8%7.4%21.4%8.4%10.4%4.3%9.4%
QoQ Delta Rev Chg LTM5.4%1.8%4.9%2.0%2.5%1.1%2.2%
Op Mgn LTM18.3%17.4%28.8%19.4%13.8%3.7%17.9%
Op Mgn 3Y Avg17.6%16.2%26.3%18.6%13.3%2.9%16.9%
QoQ Delta Op Mgn LTM-0.2%0.6%0.6%-0.1%0.9%0.1%0.3%
CFO/Rev LTM23.2%21.0%30.9%20.9%15.2%7.0%20.9%
CFO/Rev 3Y Avg18.8%19.6%26.9%20.2%16.3%11.2%19.2%
FCF/Rev LTM17.5%15.7%21.8%15.5%11.9%2.0%15.6%
FCF/Rev 3Y Avg13.1%14.4%15.0%15.1%12.4%6.3%13.7%

Valuation

BSXABTISRGMDTBDXBAXMedian
NameBoston S.Abbott L.Intuitiv.MedtronicBecton D.Baxter I. 
Mkt Cap146.9224.1159.9122.854.311.8134.8
P/S7.95.217.53.62.51.14.4
P/EBIT44.126.660.719.221.7370.235.3
P/E58.616.061.326.334.3-76.430.3
P/CFO34.324.856.617.216.715.521.0
Total Yield1.7%8.0%1.6%6.7%5.1%2.7%3.9%
Dividend Yield0.0%1.8%0.0%2.9%2.2%4.0%2.0%
FCF Yield 3Y Avg1.8%3.0%0.8%4.5%4.1%3.5%3.2%
D/E0.10.10.00.20.40.80.2
Net D/E0.10.0-0.00.20.30.70.1

Returns

BSXABTISRGMDTBDXBAXMedian
NameBoston S.Abbott L.Intuitiv.MedtronicBecton D.Baxter I. 
1M Rtn0.8%-3.8%2.9%2.0%0.8%-0.5%0.8%
3M Rtn-4.2%4.4%-14.0%7.7%6.3%-16.3%0.1%
6M Rtn4.3%-1.0%-7.6%17.8%-3.7%-19.1%-2.4%
12M Rtn14.8%11.1%-5.8%10.2%-19.7%-35.6%2.2%
3Y Rtn141.6%29.8%130.3%25.8%-13.7%-55.0%27.8%
1M Excs Rtn0.5%-4.5%1.9%0.5%-0.1%-3.0%0.2%
3M Excs Rtn-10.1%-1.9%-19.2%1.9%2.8%-20.7%-6.0%
6M Excs Rtn-21.8%-27.1%-33.7%-8.3%-29.9%-45.2%-28.5%
12M Excs Rtn-0.2%-1.7%-21.4%-4.5%-34.8%-50.2%-12.9%
3Y Excs Rtn64.3%-49.5%53.1%-54.6%-96.1%-140.8%-52.0%

Comparison Analyses

Title
0How Does Boston Scientific Stock Stack Up Against Its Peers?
1Boston Scientific vs. Texas Instruments: With Return Forecast Of 34%, Boston Scientific Is A Better Bet
2Boston Scientific vs. Intuit: With Return Forecast Of 34%-36%, Both Seem Like Good Bets
3Boston Scientific vs. Automatic Data Processing: With Return Forecast Of 34%, Boston Scientific Is A Better Bet
4Boston Scientific vs. Becton Dickinson: With Return Forecast Of 32%, Boston Scientific Is A Better Bet
5Boston Scientific vs. Abbott Laboratories: With Return Forecast Of 32%, Boston Scientific Is A Better Bet
6Boston Scientific vs. Medtronic: With Return Forecast Of 32%, Boston Scientific Is A Better Bet
7Boston Scientific vs. Baxter International: With Return Forecast Of 32%, Boston Scientific Is A Better Bet
8Boston Scientific vs. Intuitive Surgical: With Return Forecast Of 32%-36%, Both Seem Like Good Bets
9Boston Scientific vs. EchoStar: With Return Forecast Of 32%, Boston Scientific Is A Better Bet

Financials

$ Mil | FY: 12/312025Q22025Q12024Q42024Q32024Q22024Q12023Q42023Q32023Q22023Q12022Q42022Q3
Period End6/30/20253/31/202512/31/20249/30/20246/30/20243/31/202412/31/20239/30/20236/30/20233/31/202312/31/20229/30/2022
Filing Date8/1/20255/1/20252/18/202511/1/20248/1/20245/1/20242/20/202411/1/20238/3/20235/4/20232/23/202311/3/2022
Key Financials Quarterly            
Total Revenue5,0614,6634,5614,2094,1203,8563,7253,5273,5993,3893,2423,170
Ebitda1,3671,2121,0131,054808981883976794794754592
Operating Income943937790718799693618609607583527507
Net Income797674566468324494505504270314140188
EPS0.540.460.380.320.220.340.340.340.180.210.090.12
Key Financials TTM            
Total Revenue TTM18,49417,55316,74615,91015,22814,70714,24013,75713,40013,04512,68212,567
Ebitda TTM4,6464,0873,8563,7263,6483,6343,4473,3182,9342,8332,7482,490
Operating Income TTM3,3883,2443,0002,8282,7192,5272,4172,3262,2242,1352,0341,986
Net Income TTM2,5052,0321,8521,7911,8271,7731,5931,228912902698653
Growth Rates Quarterly            
Total Revenue Growth22.8%20.9%22.4%19.3%14.5%13.8%14.9%11.3%10.9%12.0%3.7%8.1%
EBITDA Growth69.2%23.5%14.7%8.0%1.8%23.6%17.1%64.9%14.6%12.0%52.0%-29.6%
Operating Income Growth18.0%35.2%27.8%17.9%31.6%18.9%17.3%20.1%17.2%21.0%10.0%10.7%
Net Income Growth146.0%36.4%12.1%-7.1%20.0%57.3%260.7%168.1%3.8%185.5%47.4%-55.1%
Margins Quarterly            
EBITDA Margin27.0%26.0%22.2%25.0%19.6%25.4%23.7%27.7%22.1%23.4%23.3%18.7%
Operating Income Margin18.6%20.1%17.3%17.1%19.4%18.0%16.6%17.3%16.9%17.2%16.3%16.0%
Net Income Margin15.7%14.5%12.4%11.1%7.9%12.8%13.6%14.3%7.5%9.3%4.3%5.9%
Cash & Debt            
Total Cash5347254142,5022,9132,329865952426570928338
Total Debt12,02711,70811,14711,25810,93611,0019,4929,2999,4549,3659,2828,934
Net Debt / (Cash)11,49310,98310,7338,7568,0238,6728,6278,3479,0288,7958,3548,596
Cash Flows Quarterly            
FCF from Operations1,2865411,4561,002813164957698658190807470
Cash Flows TTM            
FCF from Operations TTM4,2853,8123,4352,9362,6322,4772,5032,3532,1251,7741,5261,197
Returns to Shareholders Quarterly            
Dividends000000000000
Share Repurchases-0-0-0-0-0-0-0-0-0-0-0-0
Return on Invested Capital (ROIC) Quarterly            
ROIC11.6%11.3%11.0%8.0%10.0%9.0%9.9%8.2%6.1%6.6%3.1%6.3%
Return on Invested Capital (ROIC) TTM            
ROIC TTM10.3%9.6%8.8%9.1%9.4%8.3%7.8%6.2%5.3%5.4%5.1%6.0%

Segment Financials

Revenue by Segment

$ Mil20242023202220212020
Cardiovascular8,7147,6796,7213,8764,208
MedSurg5,3784,8554,3893,0663,307
Impact of foreign currency fluctuations149208766  
Other -601221981
Rhythm and Neuro   2,7523,140
Total14,24112,68211,8889,91310,736


Operating Income by Segment
$ Mil20242023202220212020
Cardiovascular2,2811,7841,5726611,137
MedSurg1,8341,4891,3681,0791,204
Corporate expenses, including hedging activities and impact of foreign currency fluctuations on-3772967-405-264
Goodwill and other intangible asset impairment charges, acquisition/divestiture-related net charges-567-789-1,070-1,208-582
Amortization expense-828-803-741-789-699
Other -60314356
Rhythm and Neuro   439666
Total2,3431,6501,199-801,518


Assets by Segment
$ Mil20242023202220212020
Goodwill14,387  9,95110,176
Other intangible assets, net6,003  5,9177,886
Cardiovascular5,988  2,4612,535
All other corporate assets5,869  7,8506,082
MedSurg2,888  1,6381,803
Other   1,133211
Rhythm and Neuro   1,8271,873
Total35,135  30,77730,566


Price Behavior

BSX Betas & Captures as of 9/30/2025

 1M2M3M6M1Y3Y
Beta-0.77-0.040.290.690.720.64
Up Beta-0.090.470.810.680.680.70
Down Beta-3.35-0.74-0.990.860.870.84
Up Capture-111%-32%2%36%56%28%
Bmk +ve Days13233574144420
Stock +ve Days8172660132414
Down Capture30%37%99%74%71%66%
Bmk -ve Days8192952107330
Stock -ve Days13253763116334

[1] Upside and downside betas calculated using positive and negative benchmark daily returns respectively

Short Interest

Short Interest: As Of Date9302025
Short Interest: Shares Quantity19,401,596
Short Interest: % Change Since 91520252.0%
Average Daily Volume13,301,110
Days-to-Cover Short Interest1.46
Basic Shares Quantity1,479,900,000
Short % of Basic Shares1.3%

Returns Analyses

Earnings Returns History

Expand for More

 Forward Returns
Earnings Date1D Returns5D Returns21D Returns
7/23/20254.5%3.2%2.8%
4/23/20254.1%8.1%10.1%
2/5/20251.4%2.4%-2.6%
10/23/2024-0.6%-3.9%2.5%
7/24/2024-1.1%-5.8%0.3%
4/24/20245.7%4.2%9.2%
1/31/20243.0%5.5%7.8%
10/26/2023-0.4%3.3%11.3%
...
SUMMARY STATS   
# Positive151517
# Negative997
Median Positive3.5%3.5%6.3%
Median Negative-1.3%-2.9%-5.9%
Max Positive6.2%9.4%17.4%
Max Negative-6.2%-5.8%-8.2%

SEC Filings

Expand for More

Report DateFiling DateFiling
6302025801202510-Q 6/30/2025
3312025501202510-Q 3/31/2025
12312024218202510-K 12/31/2024
93020241101202410-Q 9/30/2024
6302024801202410-Q 6/30/2024
3312024501202410-Q 3/31/2024
12312023220202410-K 12/31/2023
93020231101202310-Q 9/30/2023
6302023803202310-Q 6/30/2023
3312023504202310-Q 3/31/2023
12312022223202310-K 12/31/2022
93020221103202210-Q 9/30/2022
6302022804202210-Q 6/30/2022
3312022505202210-Q 3/31/2022
12312021223202210-K 12/31/2021
93020211104202110-Q 9/30/2021

Insider Activity

Expand for More

 OwnerTitleFiling DateActionPriceSharesTransacted
Value		Value of
Held Shares		Form
0FUJIMORI YOSHIAKI 7302025Sell106.992,901310,378222,646Form
1LUDWIG EDWARD J 7282025Sell106.034,000424,1201,959,330Form
2LUDWIG EDWARD J 5302025Sell104.594,000418,3682,351,121Form
3Brown Vance RSVP, GC and Corp. Secretary5222025Sell106.424,826513,5833,338,076Form
4Brown Vance RSVP, GC and Corp. Secretary4222025Sell95.094,826458,9043,441,592Form

Industry Resources

External Quote Links


Prefer one of these to Trefis? Tell us why.